24 results for “bioavailability”
Scientists at the University of South Australia say they have developed an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative diseases. Cannabidiol […]
PureTech says its oral formulation could improve the bioavailability and reduce side-effects of CBD.
Oral administration of cannabidiol by humans typically results in bioavailability levels of 6.5-20 per cent.
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
MRX1 demonstrated “cardioprotective effects” in a pre-clinical study.
Scientists at 113 Botanicals and the University of Sussex are developing new formulations for cannabis-based medicines.
Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders.
Michael Sassano CEO and founder of SOMAÍ Pharmaceuticals, explains how to find the right dose.
Experts explore how cannabis could play an important role in offering new treatment options.
Cannabis scientist Lex Pelger brings you the latest in cannabinoid research.
Hemp-based topicals are becoming increasingly popular, with an abundance of creams, balms and salves now on offer. But what’s the difference, and importantly, how do you know which is right […]
Oxford Cannabinoid Technologies is expanding its research and development into oncology.
The company that makes 13% of all CBD food supplements permitted to sell in the UK, are now one step closer to validation and full authorisation British Cannabis, registered as […]
CBD was effective at reducing stress caused by car travel or being left alone.
The project hopes to show that cannabis would be cost-effective if prescribed through the NHS for chronic pain.
The findings help us understand the therapeutic effects of THC at the molecular level.
A Polish startup is working on a technology which it claims could increase CBD absorption by 200%.
Hemp Heros is teaming up with researchers to explore how CBD can alleviate a range of health problems for both people and pups.
Researchers found limited evidence, however, to support its efficacy at doses lower than 400mg.
Pet owners are increasingly interested in leveraging CBD for their four-legged friends.
Common carrier oils found in CBD products include MCT, black cumin or hemp seed oil.
Other natural ingredients can enhance the benefits of CBD and help overall wellbeing.
The UK CBD marketplace can be a minefield amid mislabeling and false claims.
British Cannabis™ extends the brand that changed the landscape of the UK CBD market
